Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine

Author(s):
Ho, T.W.; Ho, A.P.; Ge, Y.; Assaid, C.; Gottwald, R.; MacGregor, E.A.; Mannix, L.K.; Oosterhout, W.P.J. van; Koppenhaver, J.; Lines, C.; Ferrari, M.D. (0000-0001-9691-9449); Michelson, D.
Published
2016
Publication type
Article / Letter to editor
TelcagepantCGRPmigraineheadacheprophylaxismenstrual
Date issued
2016-02-28
Language
English
Is part of
Cephalalgia (2016), Vol. 36, no. 2, p. 148-161
hdl
1887/112610
doi
10.1177/0333102415584308